Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
BMJ Open
|
September 11, 2023
Is extending eligibility for adult social care better than investing more in existing users in England? A cross-sectional evidence for multiple financial years
Francesco Longo, Karl Claxton, James Lomas, et al.
Applied Health Economics and Health Policy
|
June 29, 2022
Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study
Sebastian Hinde, Dan Howdon, James Lomas, et al.
BMJ Open
|
October 16, 2021
Causal impact of social care, public health and healthcare expenditure on mortality in England: cross-sectional evidence for 2013/2014
Stephen Martin, Francesco Longo, James Lomas, et al.
Pharmacoeconomics
|
February 13, 2019
An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis
Matthew Franklin, James Lomas, Simon Walker, et al.
Applied Health Economics and Health Policy
|
July 21, 2021
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13
Stephen Martin, James Lomas, Karl Claxton, et al.
Applied Health Economics and Health Policy
|
August 26, 2022
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies
Daniel Howdon, Sebastian Hinde, James Lomas, et al.
Health Economics
|
October 5, 2024
Unpacking the care-related quality of life effect of England's publicly funded adult social care. A panel data analysis
Andrea Salas-Ortiz, Francesco Longo, Karl Claxton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 21, 2020
Valuing health outcomes: developing better defaults based on health opportunity costs
Jessica Ochalek, Karl Claxton, James Lomas, et al.
Health Policy (Amsterdam, Netherlands)
|
March 16, 2024
Apples and oranges
Karl Claxton, James Lomas, Francesco Longo, et al.
Pharmacoeconomics
|
October 26, 2021
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
Megan Perry-Duxbury, James Lomas, Miqdad Asaria, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
BMJ Open
|
September 11, 2023
Is extending eligibility for adult social care better than investing more in existing users in England? A cross-sectional evidence for multiple financial years
Francesco Longo, Karl Claxton, James Lomas, et al.
Applied Health Economics and Health Policy
|
June 29, 2022
Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study
Sebastian Hinde, Dan Howdon, James Lomas, et al.
BMJ Open
|
October 16, 2021
Causal impact of social care, public health and healthcare expenditure on mortality in England: cross-sectional evidence for 2013/2014
Stephen Martin, Francesco Longo, James Lomas, et al.
Pharmacoeconomics
|
February 13, 2019
An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis
Matthew Franklin, James Lomas, Simon Walker, et al.
Applied Health Economics and Health Policy
|
July 21, 2021
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13
Stephen Martin, James Lomas, Karl Claxton, et al.
Applied Health Economics and Health Policy
|
August 26, 2022
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies
Daniel Howdon, Sebastian Hinde, James Lomas, et al.
Health Economics
|
October 5, 2024
Unpacking the care-related quality of life effect of England's publicly funded adult social care. A panel data analysis
Andrea Salas-Ortiz, Francesco Longo, Karl Claxton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 21, 2020
Valuing health outcomes: developing better defaults based on health opportunity costs
Jessica Ochalek, Karl Claxton, James Lomas, et al.
Health Policy (Amsterdam, Netherlands)
|
March 16, 2024
Apples and oranges
Karl Claxton, James Lomas, Francesco Longo, et al.
Pharmacoeconomics
|
October 26, 2021
The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
Megan Perry-Duxbury, James Lomas, Miqdad Asaria, et al.
Page
of 6